Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study

C Oliva,P. Bergnolo,Manuela Inguì,Lavinia Bianco,P. Pochettino,Simona Chiadò Cutin,A. Boglione,Orietta Dal Canton,F. Garetto,Alessandro Comandone

Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study

2010

C Oliva
P. Bergnolo
Manuela Inguì
Lavinia Bianco
P. Pochettino
Simona Chiadò Cutin
A. Boglione
Orietta Dal Canton
F. Garetto
Alessandro Comandone

Purpose This phase II study was designed in order to evaluate efficacy and safety of the combination of vinorelbine (VNB), fluorouracil (FU) and leucovorin (LV) in patients with metastatic breast carcinoma (MBC) previously treated with anthracyclines and taxanes.

Keywords:

Taxane
Breast cancer
Fluorouracil
Breast disease
Vinorelbine
Anthracycline
Immunology
Medicine
Metastatic breast cancer
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations